Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Not Used Anti-TNF Therapy
CzechiaStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
BulgariaStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
AustriaStudy on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Systemic Lupus Erythematosus
HungaryStudy on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss
GermanyStudy on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis
CzechiaStudy on the Effectiveness and Safety of SAR444656 for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy of GLPG3667 for Adults with Active Systemic Lupus Erythematosus
BulgariaStudy on Deucravacitinib and Apremilast for Patients with Active Psoriatic Arthritis New to Biologic Treatments or Previously on TNFα Inhibitors
BelgiumStudy on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults
FranceStudy on SAR444656 for Adults with Moderate to Severe Atopic Dermatitis
CzechiaThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
